Application for ACS Institutional Research

2025 application

Download the application (DOCX), complete it, and then email it to dcc.institutional.applications@dartmouth.edu. You will receive a return email stating that your application has been received.

The deadline for submission is February 14, 2025.

Policies and instruction

In addition to information on the ACS website, the 66-page American Cancer Society Institutional Research Grants Policies and Instructions document (PDF) is available.

If you have any questions, contact Richard Lucius at richard.w.lucius.jr@dartmouth.edu or 603-646-5498.

Current recipients

  • Prerna Malaney, PhD, Assistant Professor, Department of Biochemistry and Cell Biology, Geisel School of Medicine
    Examining the Genetic Underpinnings of High-Risk Pediatric Burkitt Lymphoma
  • Aurora Quaye, MD, Faculty Scientist I, Center for Outcomes Research and Evaluation, Maine Health Research Institute
    Investigating the Association between Polyp Detection and Sedation during Colonoscopy
  • Frederick Varn, PhD, Assistant Professor, The Jackson Laboratory for Genomic Medicine
    Modeling the effects of brain aging on glioblastoma transcriptional evolution in mice

Past recipients

Congratulations to the past ACS Research Grant recipients.

2023

  • Britt Goods, PhD
    Creating a scalable, biopsy-derived organoid model pipeline for endometrial cancer 
  • Katherine Hixon, PhD
    In Vivo Cryogel Scaffolds with Radiation Therapy for MBD Bone Regeneration
  • Shauna McVorran, MD, MHSA
    Transrectal Optical Dosimetry in High Dose Rate Brachytherapy 

2022

  • Courtney Stevens, PhD
    Measuring breast cancer survivor’s subjective response to exercise using a novel, smartwatch-based ecological momentary assessment sampling method: A stakeholder-centered test of feasibility and acceptability
  • Siming Zhao, PhD
    Novel Statistical Approaches to Subtyping Cancer Using High-dimensional Data

2020

  • Gabriel Brooks, MD, MPH
    Pretreatment plasma uracil as a biomarker for sub-therapeutic dosing of 5-fluorouracil during chemotherapy for gastrointestinal cancer
  • Garrett Wasp, MD
    Developing an Experimental Framework to Evaluate Oncologist Emotion Regulation and its Effect on Prognostic Disclosure
  • George Zanazzi, MD
    Brain tumor microenvironment in metastatic small cell carcinoma

2019

  • Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN
    Prevalence of risk for opioid use disorder in patients receiving treatment at the Norris Cotton Cancer Center 
  • Chai-Hao Lucas Chang, PhD  
    The effect of immunotherapy on metabolism in tumor-infiltrating T cells 
  • Shengdong Ke, PhD 
    The potential role of m6A mRNA-mediated regulation of cancer cell state transition 
  • Andrew P. Loehrer, MD
    Use of state cancer registries to evaluate the influence of Medicaid expansion and Section 1115 waivers on access to and equity of cancer care 
  • Garrett Wasp, MD 
    Developing an Experimental Framework to Evaluate Oncologist Emotion Regulation and its Effect on Prognostic Disclosure